Companies: 10,795·Total market cap: $144.5T
China Pharma Holdings, Inc.

China Pharma Holdings, Inc.

CPHIAMEXHealthcare● Active
$0.71
$-0.00(-0.17%)
Market Cap$2271811
P/E Ratio
52W High$2.05
52W Low$0.38
Overview

China Pharma Holdings, Inc.(CPHI)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CPHI · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$4.14M$4.53M$7.01M$8.10M$9.64M
Cost of Revenue$4.28M$6.51M$7.29M$8.60M$9.29M
Gross Profit($0.13M)($1.99M)($0.28M)($0.49M)$0.35M
Gross Margin %(computed)-3.18%-43.84%-4.01%-6.09%3.62%
Operating Expenses
R&D Expenses$0.28M$0.28M$0.24M$0.19M$0.32M
G&A Expenses$2.45M$1.78M$1.47M$1.89M$1.65M
Total Operating Expenses$2.96M$2.60M$2.47M$3.06M$3.21M
Operating Income($3.09M)($4.59M)($2.75M)($3.55M)($2.86M)
Operating Margin %(computed)-74.53%-101.32%-39.25%-43.79%-29.67%
Interest Income$0.00M$0.01M$0.01M$0.01M$0.00M
Interest Expense$0.10M$0.15M$0.33M$0.43M$0.54M
Income Before Tax($3.19M)($4.74M)($3.08M)($3.97M)($3.40M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($3.19M)($4.74M)($3.08M)($3.97M)($3.40M)
Net Margin %(computed)-76.91%-104.58%-43.91%-49.02%-35.26%
Per Share & EBITDA
EPS (Basic)$-0.74$-0.27$-0.29$-1.94$-0.85
Wtd Avg Shares4.29M17.46M10.60M5.26M4.61M
EBITDA($1.51M)($1.96M)$0.01M($0.84M)$0.23M
EBITDA Margin %(computed)-36.35%-43.37%0.12%-10.34%2.39%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解China Pharma Holdings, Inc.

关于China Pharma Holdings, Inc.(CPHI)损益表

China Pharma Holdings, Inc.(CPHI)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CPHI实现营收$0.00B,毛利润($0.00B)(毛利率-3.18%),净利润($0.00B)(净利率-76.91%)。

常见问题

CPHI · 4 问

China Pharma Holdings, Inc.(CPHI)2025财年营收为$0.00B,同比down8.5%。

CPHI revenueCPHI salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08